Evaluation of circulatory microRNA-196 levels during the progression of chronic renal (kidney) disease of unknown etiology

https://doi.org/10.53730/ijhs.v6nS2.6406

Authors

  • N. Rajyalakshmi Department of Research and Development, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamilnadu, India & Department of Pharmacology, Government Medical College, Srikakulam, Andhrapradesh, India
  • R. Vijayaraghavan Department of Research and Development, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamilnadu, India
  • S. Senthilkumar Department of Research and Development, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamilnadu, India
  • Durairaj Sekar Cellular and Molecular Biology Research Centre, Saveetha Dental College and Hospital, Chennai, Tamilnadu, India

Keywords:

chronic renal disease (CRD), chronic renal disease of unknown etiology (CRDU), microRNA-196, RT-qPCR

Abstract

Chronic renal disease of unknown etiology is prevalent & clinically silent until its late stages at which point patients may suffer significant irreversible damage or mortality in the lack of early screening & intervention. If diagnosed early stage 1-3 the progression of chronic renal disease can be altered and complications reduced. Current diagnosing markers of renal function, serum creatinine, blood urea and uric acid have been shown to be lacking high predictive value. So, there is a need for next generation biomarkers suitable for Chronic renal disease of unknown etiology and should not be influenced by age, sex, nutritional status, current health concern. microRNAs appears to be very stable in tissues & biological fluids even under adverse conditions like extreme pH, long term room temperature storage, multiple freeze thaw cycles & RNAase activity. microRNAs elaborate in renal development, maintenance of renal function & progression of renal disease. miRNA-196 is a renal derived biomarker, extensively distributed in renal, shows an important role in renal diseases & superior to other renal biomarkers. The aim of present study is to evaluate circulatory miRNA-196 during progression of chronic renal disease of unknown etiology. 

Downloads

Download data is not yet available.

References

Tatapudi RR, Rentala S, Gullipalli P, et al, 2018. High Prevalence of CKD of Unknown Etiology in Uddanam, India. Kidney Int Rep. 4(3), 380-389. doi:10.1016/j.ekir.2018.10.006

Gowrishankar S, Koshy P, Mathew M, et al, 2020. Pathology of Uddanam Endemic Nephropathy. Indian J Nephrol. 30(4), 253-255. doi:10.4103/ijn.IJN_363_18

Anupama YJ, Kiran SK, Hegde SN, 2019. Heavy Metals and Pesticides in Chronic Kidney Disease - Results from a Matched Case-Control Study from a Rural Population in Shivamogga District in South India. Indian J Nephrol. 29(6), 402-409.

Anupama YJ, Sankarasubbaiyan S, Taduri G, 2020. Chronic Kidney Disease of Unknown Etiology: Case Definition for India - A Perspective. Indian J Nephrol. 30(4), 236-240.

Gifford FJ, Gifford RM, Eddleston M, et al, 2017. Endemic Nephropathy Around the World. Kidney Int Rep. 2(2), 282-292. doi:10.1016/j.ekir.2016.11.003

Ganguli A, 2016. Uddanam Nephropathy/Regional Nephropathy in India: Preliminary Findings and a Plea for Further Research. Am J Kidney Dis. 68(3), 344-348. doi:10.1053/j.ajkd.2016.04.012

Cockwell P, Fisher LA. 2020. The global burden of chronic kidney disease. Lancet. 395(10225), 662-664. doi: 10.1016/S0140-6736(19)32977-0.

Han WK, Bailly V, Abichandani R, et al, 2002. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62(1), 237-244. doi:10.1046/j.1523-1755.2002.00433.x

Jha V, Garcia-Garcia G, Iseki K, et al, 2013. Chronic kidney disease: global dimension and perspectives. Lancet. 382(9888), 260-272. doi:10.1016/S0140-6736(13)60687-X

Kato M, Arce L, Natarajan R, 2009. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 4(7), 1255-1266. doi:10.2215/CJN.00520109

Zhang C, Liang S, Cheng S, et al, 2018. Urinary miR-196a predicts disease progression in patients with chronic kidney disease. J Transl Med. 16(1), 91. doi: 10.1186/s12967-018-1470-2.

Bhaskaran M, Mohan M, 2014. MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease. Veterinary Pathology. 51(4), 759-774. doi:10.1177/0300985813502820

Li JY, Yong TY, Michael MZ, et al, 2010. Review: The role of microRNAs in kidney disease. Nephrology (Carlton).15(6), 599-608. doi:10.1111/j.1440-1797.2010.01363.x

Ho J, Kreidberg JA, 2013. MicroRNAs in renal development. Pediatr Nephrol. 28(2), 219-225. doi:10.1007/s00467-012-2204-y

Wei Q, Mi QS, Dong Z, 2013. The regulation and function of microRNAs in kidney diseases. IUBMB Life. 65(7), 602-614. doi:10.1002/iub.1174

Chandrasekaran K, Karolina DS, Sepramaniam S, et al, 2012. Role of microRNAs in kidney homeostasis and disease. Kidney International. 81(7), 617-627. doi:10.1038/ki.2011.448

Lagos-Quintana M, Rauhut R, Meyer J, et al, 2003. New microRNAs from mouse and human. RNA. 9(2), 175-179. doi:10.1261/rna.2146903

Meng J, Li L, Zhao Y, et al, 2016. MicroRNA-196a/b mitigate renal fibrosis by targeting TGF-beta receptor2. J Am Soc Nephrol. 27(10), 3006-3021. doi:10.1681/ASN.2015040422

Livak KJ, Schmittgen TD, 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) Method. Methods. 25(4), 402-408.

Published

22-04-2022

How to Cite

Rajyalakshmi, N., Vijayaraghavan, R., Senthilkumar, S., & Sekar, D. (2022). Evaluation of circulatory microRNA-196 levels during the progression of chronic renal (kidney) disease of unknown etiology. International Journal of Health Sciences, 6(S2), 5624–5630. https://doi.org/10.53730/ijhs.v6nS2.6406

Issue

Section

Peer Review Articles